Longitudinal study of influenza molecular viral shedding in hutterite communities

Journal of Infectious Diseases

Volumn 206, Issue 7, 2012, Pages 1078-1084

  Loeb, Mark ^a,b   Singh, Paramjit K ^a   Fox, Julie ^c   Russell, Margaret L ^d   Pabbaraju, Kanti ^c   Zarra, Danielle ^c   Wong, Sallene ^c   Neupane, Binod ^a   Singh, Pardeep ^a   Webby, Richard ^e   Fonseca, Kevin ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Provincial Laboratory for Public Health   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CANADA; CHILD; ETHNIC GROUP; HUMAN; HUTTERITE; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; LABORATORY DIAGNOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NOSE SMEAR; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASON; SYMPTOMATOLOGY; VIRUS LOAD; VIRUS SHEDDING;

ADOLESCENT; ALBERTA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; NASAL MUCOSA; PHARYNX; PROTESTANTISM; SENTINEL SURVEILLANCE; VIRAL LOAD; VIRUS SHEDDING;

EID: 84866060190     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis450     Document Type: Article

References (34)

1. Langley JM, Faughnan ME. Prevention of influenza in the general population. CMAJ 2004; 171:1213-22. (Pubitemid 39518016)
2. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40. (Pubitemid 39223224)
3. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, Couch RB. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 1991; 133:296-304.
4. Opatowski L, Fraser C, Griffin J, et al. Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 southern hemisphere countries. PLoS Pathog 2011; 9:e1002225.
5. Clements ML, Betts RF, Murphy BR. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Wash-ington/80 (H3N2) wild-type virus infection. Lancet 1984; 1:705-8. (Pubitemid 14171146)
6. Clements ML, Betts RF, Tierney EL, Murphy BR. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine. J Clin Microbiol 1986; 23:73-6. (Pubitemid 16186973)
7. Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J Infect Dis 1988; 158:1209-19. (Pubitemid 19023284)
8. Clements ML, Snyder MH, Sears SD, Maassab HF, Murphy BR. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers. J Infect Dis 1990; 161:869-77. (Pubitemid 20148316)
9. Treanor JJ, Betts RF. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine 1998; 16:1756-60. (Pubitemid 28545106)
10. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167:775-85. (Pubitemid 351451744)
11. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-9. (Pubitemid 28084248)
12. Murphy AW, Platts-Mills TA, Lobo M, Hayden F. Respiratory nitric oxide levels in experimental human influenza. Chest 1998; 114:452-6. (Pubitemid 28387522)
13. Hayden FG, Trenor JJ, Betts RF, et al. Safety and efficacy of the neur-aminidase inhibitor GG167 in experimental human influenza. JAMA 1996; 275:295-9. (Pubitemid 26028588)
14. Clements ML, Subbarao EK, Fries LF, et al. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J Clin Microbiol 1992; 30:655-62.
15. Gentile D, Doyle W, Whiteside T, et al. Increased interleukin- 6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol 1998; 5:604-8. (Pubitemid 29030752)
16. Hayden FG, Tunkel AR, Treanor JJ, et al. Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans. Antimicrob Agents Chemother 1994; 38:1178-81. (Pubitemid 24150862)
17. Walker JB, Hussey EK, Treanor JJ, et al. Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. J Infect Dis 1997; 176:1417-22. (Pubitemid 27518138)
18. Doyle WJ, Skoner DP, Hayden F, et al. Nasal and otologic effects of experimental influenza A virus infection. Ann Otol Rhinol Laryngol 1994; 103:59-69. (Pubitemid 24027682)
19. Doyle WJ, Alper CM, Buchman CA, et al. Illness and ontological changes during upper respiratory virus infection. Laryngoscope 1999; 109:324-8. (Pubitemid 29075580)
20. Buchman CA, Doyle WJ, Skoner DP, et al. Influenza A virus-induced acute otitis media. J Infect Dis 1995; 172:1348-51.
21. Youngner JS, Treanor JJ, Betts RF, et al. Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans. J Clin Microbiol 1994; 32:750-4. (Pubitemid 24062955)
22. Bjornson AB, Mellencamp MA, Schiff GM. Complement is activated in the upper respiratory tract during influenza virusinfection. Am Rev Respir Dis 1991; 143:1062-6.
23. Couch RB, Douglas RG Jr, Fedson DS, et al. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis 1971; 124:473-80.
24. Little JW, Douglas RG Jr, Hall WJ, et al. Attenuated influenza produced by experimental intranasal inoculation. J Med Virol 1979; 3:177-88. (Pubitemid 9155020)
25. Phillpotts RJ, Higgins PG, Willman JS, et al. Intranasal lymphoblas-toid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers. J Interferon Res 1984; 4:535-41. (Pubitemid 14023309)
26. Whicher JT, Chambers RE, Higginson J, et al. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J Clin Pathol 1985; 38:312-6. (Pubitemid 15134088)
27. Lau LL, Cowling BJ, Fang VJ, et al. Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis 2010; 201:1509-16.
28. Daley P, Castriciano S, Chernesky M, Smieja M. Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients. J Clin Microbiol 2006; 44:2265-7. (Pubitemid 43902191)
29. Smieja M, Castriciano S, Carruthers S, et al. Development and evaluation of a flocked nasal midturbinate swab for self-collection in respiratory virus infection diagnostic testing. J Clin Microbiol 2010; 48: 3340-2.
30. Larios OE, Coleman BL, Drews SJ, et al. Self-collected midturbinate swabs for the detection of respiratory viruses in adults with acute respiratory illnesses. PLoS One 2011; 6:e21335.
31. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15.
32. Wright PF, Thompson J, Karzon DT, et al. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol 1980; 112: 814-9.
33. Frank AL, Taber LH, Wells CR, Wells JM, Glezen WP, Paredes A. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981; 144:433-41. (Pubitemid 12249626)
34. Hall CB, Dolin R, Gala CL, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics 1987; 80:275-82. (Pubitemid 17126807)